Pimavanserin Tartrate API
1 Inquiries
706782-28-7
Pharmaceutical Grade
99%
25kg/Cardboard Drum
2023-05-25
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionChEBI: A tartrate salt that is the hemitartrate salt of pimavanserin. An atypical antipsychotic that is used for treatment of hallucinations and delusions associated with Parkinson's disease.Basic Info
-
Product Name:
Unii-na83F1sjsr
Other Name:N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1);N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide;Unii-na83F1sjsr;PiMavanserin Tartrate;Pimavanserin tartrate or ACP 103;ACP-103;BVF-048;Nuplazid
CAS No.:706782-28-7
Molecular Formula:C29H40FN3O8
InChIKeys:XTTVNKCYECPJOF-MVELKYERNA-N
Molecular Weight:577.65
EC Number:1806241-263-5
Color/Form:White to off-white
HScode:29299090
Categories:
Characteristics-
Critical Temperature & Pressure:
Store at -20°C
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Betahistine Mesylate,Azilsartan Medoxomil Potassium,Pimavanserin Tartrate,Iguratimod
-
Location:
Building 4, Juanhu Int. Sci & Innovation Park, No. 500, Shuiyueting East Road, Xishi Street, Haining, Jiaxing, Zhejiang
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
20
-
Total Annual Revenue:
$25 million-$50 million
-
Total Employees:
201-300
-
Year of Establishment:
2021
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted 
India
Pimavanserin tartrate
2 G Feb 1, 2024 Post an enquiry for this product
